The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000132.4(F8):c.766T>A (p.Tyr256Asn)

CA414918961

618107 (ClinVar)

Gene: F8 (HGNC:2157)
Condition: hemophilia A (MONDO:0010602)
Inheritance Mode: X-linked inheritance
UUID: 56810547-f2ab-47a5-8292-247dc9d7b8e4
Approved on: 2026-02-06
Published on: 2026-02-27

HGVS expressions

NM_000132.4(F8):c.766T>A (p.Tyr256Asn)
NM_000132.4:c.766T>A
NC_000023.11:g.154984708A>T
CM000685.2:g.154984708A>T
NC_000023.10:g.154212983A>T
CM000685.1:g.154212983A>T
NC_000023.9:g.153866177A>T
NG_011403.1:g.43016T>A
NG_011403.2:g.43016T>A
ENST00000360256.9:c.766T>A
ENST00000647125.1:c.*552T>A
ENST00000360256.8:c.766T>A
ENST00000423959.5:c.661T>A
NM_000132.3:c.766T>A
More

Likely Pathogenic

Met criteria codes 4
PP4_Moderate PM2_Supporting PS4_Moderate PP3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Coagulation Factor Deficiency Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for F8 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Coagulation Factor Deficiency VCEP
The NM_000132.4(F8):c.766T>A; p.Tyr256Asn is a missense variant that is absent from gnomAD v2.1.1/gnomAD v3 meeting PM2_Supporting. The variant is predicted to have a deleterious effect with a REVEL score of 0.942, which is greater than the ClinGen CFD threshold for PP3 (>0.6) meeting PP3. This variant has been observed in at least 4 probands in the literature with mild hemophilia A (PP4_Moderate, PMID:29296726; PS4_Moderate, PMID:29296726, 16786531). In summary, this variant meets the criteria to be classified as likely pathogenic for hemophilia A. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel using v1.0.0 rule specifications for F8: PS4_Moderate, PP4_Moderate, PM2_Supporting, PP3.
Met criteria codes
PP4_Moderate
The c.766T>A, p.Tyr256Asn variant has been observed in a patient with mild hemophilia A without type 2N von Willebrand disease ruled out (2 points PP4, PMID:29296726, PP4_Moderate).
PM2_Supporting
The c.766T>A, p.Tyr256Asn variant is absent from population databases (gnomAD v2.1.1/gnomAD v3; PM2_Supporting)
PS4_Moderate
The c.766T>A, p.Tyr256Asn variant has been observed at least 3 patients with mild hemophilia A without type 2N von Willebrand disease ruled out (2 points PS4, PMID:29296726, 1 point PS4, PMID:16786531; PS4_Moderate).
PP3
The c.766T>A, p.Tyr256Asn variant is predicted to have a deleterious effect (REVEL score of 0.942; PP3), which is greater than the Clingen CFD threshold for PP3 (>0.6).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.